Emergent BioSolutions Inc.

EBS· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$7.41+2.63%

2026-08-03

Financials

Valuation Metrics

Emergent BioSolutions Inc.'s Market Cap is $382M. At end of 2025 it was $661M. Ranked #2898 of 3,112 in US market (top 93%), #1616 of 1,667 on NYSE (top 97%), #232 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 86%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$382M	US#2,898/3,112 Sec#232/269
Revenue	$677M	US#2,192/3,112 Sec#69/269
Net Income	$-9M	US—/3,112 Sec—/269
Total Assets	$1.32B	US#2,311/3,112 Sec#77/269
Net Assets	$523M	US#2,222/3,112 Sec#109/269
Value
P/B	0.73x	US#159/3,112 Sec#5/269
P/S	0.56x	US#326/3,112 Sec#3/269
EV/EBITDA	5.15x	US#165/3,112 Sec#10/269
FCF Yield	35.41%	US#51/3,112 Sec#2/269
Profitability
ROE	-1.64%	US#2,216/3,112 Sec#77/269
ROA	-0.65%	US#2,278/3,112 Sec#78/269
Op. Margin	10.52%	US#1,589/3,112 Sec#67/269
Revenue Growth	-29.75%	US#2,829/3,112 Sec#156/269
Earnings Growth	-90.00%	US#2,028/3,112 Sec#63/269
Financial Health
Debt Ratio	152.42%	US#1,515/3,112 Sec#187/269
Total Debt	$574M	US#1,743/3,112 Sec#56/269
FCF	$135M	US#1,541/3,112 Sec#53/269
Cash	$160M	US#1,894/3,112 Sec#138/269
Current Ratio	4.29x	US#560/3,112 Sec#162/269
Net Debt/EBITDA	2.68x	US#1,565/3,112 Sec#66/269
Performance
1Y Return	31.62%	US#1,337/3,112 Sec#154/269
1M Return	-10.51%	US#2,624/3,112 Sec#170/269
From 52W High	-47.30%	US#2,729/3,112 Sec#212/269
1Y MDD	-48.06%	US#2,328/3,112 Sec#179/269
Trading
Volume	352,709 shares	US#2,313/3,112 Sec#229/269
Trading Value	$3M	US#2,861/3,112 Sec#240/269
Per Share
EPS	$0.98	US#1,626/3,112 Sec#54/269
BPS	$9.77	US#1,803/3,112 Sec#63/269